HRP20010747A2 - Novel synthesis and crystallization of piperazine ring-containing compounds - Google Patents

Novel synthesis and crystallization of piperazine ring-containing compounds Download PDF

Info

Publication number
HRP20010747A2
HRP20010747A2 HR20010747A HRP20010747A HRP20010747A2 HR P20010747 A2 HRP20010747 A2 HR P20010747A2 HR 20010747 A HR20010747 A HR 20010747A HR P20010747 A HRP20010747 A HR P20010747A HR P20010747 A2 HRP20010747 A2 HR P20010747A2
Authority
HR
Croatia
Prior art keywords
mirtazapine
methyl
phenyl
piperazine
cyanopyridyl
Prior art date
Application number
HR20010747A
Other languages
English (en)
Croatian (hr)
Inventor
Claude Singer
Anita Liberman
Nina Finkelstein
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of HRP20010747A2 publication Critical patent/HRP20010747A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
HR20010747A 1999-04-19 2000-04-18 Novel synthesis and crystallization of piperazine ring-containing compounds HRP20010747A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13004799P 1999-04-19 1999-04-19
PCT/US2000/010357 WO2000062782A1 (en) 1999-04-19 2000-04-18 Novel synthesis and crystallization of piperazine ring-containing compounds

Publications (1)

Publication Number Publication Date
HRP20010747A2 true HRP20010747A2 (en) 2002-12-31

Family

ID=22442814

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20010747A HRP20010747A2 (en) 1999-04-19 2000-04-18 Novel synthesis and crystallization of piperazine ring-containing compounds

Country Status (16)

Country Link
JP (1) JP2004500324A (enExample)
KR (1) KR20020019902A (enExample)
CN (4) CN1679586A (enExample)
CA (1) CA2368815A1 (enExample)
CZ (1) CZ20013658A3 (enExample)
HK (1) HK1044116A1 (enExample)
HR (1) HRP20010747A2 (enExample)
HU (1) HUP0200839A3 (enExample)
IL (1) IL146023A0 (enExample)
PL (1) PL366289A1 (enExample)
RU (1) RU2001128229A (enExample)
SK (1) SK14672001A3 (enExample)
TR (1) TR200103028T2 (enExample)
WO (1) WO2000062782A1 (enExample)
YU (1) YU74101A (enExample)
ZA (1) ZA200108220B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001038329A1 (en) * 1999-11-24 2001-05-31 Sumika Fine Chemicals Co., Ltd. Anhydrous mirtazapine crystals and process for producing the same
WO2001042239A1 (en) * 1999-12-13 2001-06-14 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a pyridinemethanol compound
US6660730B2 (en) * 2000-11-27 2003-12-09 Sumika Fine Chemicals Co., Ltd. Anhydrous mirtazapine and process for preparing the same
UA83666C2 (ru) * 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
ES2246161B1 (es) * 2004-07-22 2007-04-01 Medichem, S.A. Proceso mejorado para la fabricacion de mirtazapina.
JP4848704B2 (ja) * 2004-08-24 2011-12-28 住友化学株式会社 ２−（４−メチル−２−フェニルピペラジン−１−イル）−３−シアノピリジンの製造方法
JP5192707B2 (ja) 2007-03-22 2013-05-08 住友化学株式会社 ミルタザピンの製造方法
US7994314B2 (en) 2007-04-11 2011-08-09 N.V. Organon Method for the preparation of an enantiomerically pure benzazepine
WO2008125578A2 (en) 2007-04-11 2008-10-23 N.V. Organon A method for the preparation of mirtazapine
KR101485418B1 (ko) 2013-05-29 2015-01-26 주식회사 메디켐코리아 고순도 미르타자핀의 제조방법
JP2017088564A (ja) * 2015-11-13 2017-05-25 株式会社トクヤマ ミルタザピンの製造方法
JP6571497B2 (ja) * 2015-11-13 2019-09-04 株式会社トクヤマ ミルタザピンの製造方法
CN108191873B (zh) * 2018-01-08 2021-09-24 山东省食品药品检验研究院 一种盐酸米安色林的纯化方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.

Also Published As

Publication number Publication date
CZ20013658A3 (cs) 2002-08-14
CN1680374A (zh) 2005-10-12
CA2368815A1 (en) 2000-10-26
CN1679586A (zh) 2005-10-12
ZA200108220B (en) 2006-02-26
WO2000062782A1 (en) 2000-10-26
HUP0200839A3 (en) 2003-05-28
JP2004500324A (ja) 2004-01-08
HUP0200839A2 (en) 2002-08-28
SK14672001A3 (sk) 2002-11-06
RU2001128229A (ru) 2003-07-10
PL366289A1 (en) 2005-01-24
IL146023A0 (en) 2002-07-25
YU74101A (sh) 2004-09-03
CN1356903A (zh) 2002-07-03
TR200103028T2 (tr) 2002-01-21
CN1680365A (zh) 2005-10-12
KR20020019902A (ko) 2002-03-13
HK1044116A1 (zh) 2002-10-11

Similar Documents

Publication Publication Date Title
EP0299470B1 (de) Imidazo[1,2-a]pyridine
HRP20010747A2 (en) Novel synthesis and crystallization of piperazine ring-containing compounds
JP6114881B2 (ja) 「３−（５−置換オキシ−２，４−ジニトロ−フェニル）−２−オキソ−プロピオン酸エステル」の化合物、そのプロセスおよび用途
HRP20020819A2 (en) Novel processes for preparing torsemide intermediate
US6576764B2 (en) Synthesis and crystallization of piperazine ring-containing compounds
TWI777079B (zh) 稠合三環γ-胺基酸衍生物的製備方法及其中間體
US20030069417A1 (en) Novel synthesis and crystallization of piperazine ring-containing compounds
CN111233750A (zh) 一种3,3-二氟-1,2,3,6-四氢哌啶类衍生物及其制备方法
US20040176591A1 (en) Novel synthesis and crystallization of peperazine ring-containing compounds
US3058992A (en) Intermediates for the preparation of
NZ199139A (en) Benz(phenoxyalkoxy)-9-oxo-1h,9h-benzopyrano-(2,3-d)-v-triazoles
Carney et al. Investigations in Heterocycles. XVIII. The Synthesis of 1, 2-Disubstituted 5, 6, 7, 8-Tetrahydro-4-quinazolinethiones1
JPS588082A (ja) 置換されたピロロ〔２，１−ｂ〕キナゾリンおよびピリド〔２，１−ｂ〕キナゾリンおよびそれらの製造法
US2812326A (en) Purification of bis-dehydroabietyl-ethyelenediamine-di-penicillinate
SU584782A3 (ru) Способ получени производных аминоимидазоизохинолина или их солей
EP0026675B1 (en) 1-azaxanthone-3-carboxylic acids, their preparation and pharmaceutical compositions containing them
CA2287566A1 (en) 9,10-diazatricyclo¬4.2.1.12,5|decane and 9,10-diazatricyclo¬3.3.1.12,6|decane derivatives having analgesic activity
AU2005201117A1 (en) Novel synthesis and crystallization of piperazine ring-containing compounds
US3202712A (en) 1-cyclohexene-4-bis (omicron-chlorobenzylaminomethyl) and derivatives
IE43503B1 (en) Acid accition salt of a substituted pyrido-dioxin derivative
JPS5924992B2 (ja) ピリド〔２，３−ｄ〕ピリミジン誘導体およびその製法
JPS5976091A (ja) ピリド〔１，２，３−ｄｅ〕〔１，４〕ベンゾチアジン誘導体
GB2033382A (en) Production of N-(4'-Chloro-3- sulphamoyl-benzenesulphonyl)-N- methyl-2-aminomethyl-2-methyl tetrahydrofuran
US3658794A (en) Alkyl mitomycins
JPS59184184A (ja) ７，８，９，１０−テトラヒドロチエノ〔３，２−ｅ〕ピリド〔４，３−ｂ〕−インド−ル、その製造法及びそれらを含む医薬

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20050329

Year of fee payment: 6

ODBI Application refused